Flortaucipir tau PET imaging in semantic variant primary progressive aphasia
ObjectiveThe semantic variant of primary progressive aphasia (svPPA) is typically associated with frontotemporal lobar degeneration (FTLD) with longTAR DNA-binding protein (TDP)-43-positive neuropil threads and dystrophic neurites (type C), and is only rarely due to a primary tauopathy or Alzheimer’...
Saved in:
Published in | Journal of neurology, neurosurgery and psychiatry Vol. 89; no. 10; pp. 1024 - 1031 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BMJ Publishing Group LTD
01.10.2018
BMJ Publishing Group |
Series | Research paper |
Subjects | |
Online Access | Get full text |
ISSN | 0022-3050 1468-330X 1468-330X |
DOI | 10.1136/jnnp-2017-316409 |
Cover
Loading…
Abstract | ObjectiveThe semantic variant of primary progressive aphasia (svPPA) is typically associated with frontotemporal lobar degeneration (FTLD) with longTAR DNA-binding protein (TDP)-43-positive neuropil threads and dystrophic neurites (type C), and is only rarely due to a primary tauopathy or Alzheimer’s disease. We undertook this study to investigate the localisation and magnitude of the presumed tau Positron Emission Tomography (PET) tracer [18F]Flortaucipir (FTP; also known as T807 or AV1451) in patients with svPPA, hypothesising that most patients would not show tracer uptake different from controls.MethodsFTP and [11C]Pittsburgh compound B PET imaging as well as MRI were performed in seven patients with svPPA and in 20 controls. FTP signal was analysed by visual inspection and by quantitative comparison to controls, with and without partial volume correction.ResultsAll seven patients showed elevated FTP uptake in the anterior temporal lobe with a leftward asymmetry that was not observed in healthy controls. This elevated FTP signal, largely co-localised with atrophy, was evident on both visual inspection and quantitative cortical surface-based analysis. Five patients were amyloid negative, one was amyloid positive and one has an unknown amyloid status.ConclusionsIn this series of patients with clinical profiles, structural MRI and amyloid PET imaging typical for svPPA, FTP signal was unexpectedly elevated with a spatial pattern localised to areas of atrophy. This raises questions about the possible off-target binding of this tracer to non-tau molecules associated with neurodegeneration. Further investigation with autopsy analysis will help illuminate the binding target(s) of FTP in cases of suspected FTLD-TDP neuropathology. |
---|---|
AbstractList | The semantic variant of primary progressive aphasia (svPPA) is typically associated with frontotemporal lobar degeneration (FTLD) with longTAR DNA-binding protein (TDP)-43-positive neuropil threads and dystrophic neurites (type C), and is only rarely due to a primary tauopathy or Alzheimer's disease. We undertook this study to investigate the localisation and magnitude of the presumed tau Positron Emission Tomography (PET) tracer [18F]Flortaucipir (FTP; also known as T807 or AV1451) in patients with svPPA, hypothesising that most patients would not show tracer uptake different from controls.OBJECTIVEThe semantic variant of primary progressive aphasia (svPPA) is typically associated with frontotemporal lobar degeneration (FTLD) with longTAR DNA-binding protein (TDP)-43-positive neuropil threads and dystrophic neurites (type C), and is only rarely due to a primary tauopathy or Alzheimer's disease. We undertook this study to investigate the localisation and magnitude of the presumed tau Positron Emission Tomography (PET) tracer [18F]Flortaucipir (FTP; also known as T807 or AV1451) in patients with svPPA, hypothesising that most patients would not show tracer uptake different from controls.FTP and [11C]Pittsburgh compound B PET imaging as well as MRI were performed in seven patients with svPPA and in 20 controls. FTP signal was analysed by visual inspection and by quantitative comparison to controls, with and without partial volume correction.METHODSFTP and [11C]Pittsburgh compound B PET imaging as well as MRI were performed in seven patients with svPPA and in 20 controls. FTP signal was analysed by visual inspection and by quantitative comparison to controls, with and without partial volume correction.All seven patients showed elevated FTP uptake in the anterior temporal lobe with a leftward asymmetry that was not observed in healthy controls. This elevated FTP signal, largely co-localised with atrophy, was evident on both visual inspection and quantitative cortical surface-based analysis. Five patients were amyloid negative, one was amyloid positive and one has an unknown amyloid status.RESULTSAll seven patients showed elevated FTP uptake in the anterior temporal lobe with a leftward asymmetry that was not observed in healthy controls. This elevated FTP signal, largely co-localised with atrophy, was evident on both visual inspection and quantitative cortical surface-based analysis. Five patients were amyloid negative, one was amyloid positive and one has an unknown amyloid status.In this series of patients with clinical profiles, structural MRI and amyloid PET imaging typical for svPPA, FTP signal was unexpectedly elevated with a spatial pattern localised to areas of atrophy. This raises questions about the possible off-target binding of this tracer to non-tau molecules associated with neurodegeneration. Further investigation with autopsy analysis will help illuminate the binding target(s) of FTP in cases of suspected FTLD-TDP neuropathology.CONCLUSIONSIn this series of patients with clinical profiles, structural MRI and amyloid PET imaging typical for svPPA, FTP signal was unexpectedly elevated with a spatial pattern localised to areas of atrophy. This raises questions about the possible off-target binding of this tracer to non-tau molecules associated with neurodegeneration. Further investigation with autopsy analysis will help illuminate the binding target(s) of FTP in cases of suspected FTLD-TDP neuropathology. The semantic variant of primary progressive aphasia (svPPA) is typically associated with frontotemporal lobar degeneration (FTLD) with longTAR DNA-binding protein (TDP)-43-positive neuropil threads and dystrophic neurites (type C), and is only rarely due to a primary tauopathy or Alzheimer's disease. We undertook this study to investigate the localisation and magnitude of the presumed tau Positron Emission Tomography (PET) tracer [ F]Flortaucipir (FTP; also known as T807 or AV1451) in patients with svPPA, hypothesising that most patients would not show tracer uptake different from controls. FTP and [ C]Pittsburgh compound B PET imaging as well as MRI were performed in seven patients with svPPA and in 20 controls. FTP signal was analysed by visual inspection and by quantitative comparison to controls, with and without partial volume correction. All seven patients showed elevated FTP uptake in the anterior temporal lobe with a leftward asymmetry that was not observed in healthy controls. This elevated FTP signal, largely co-localised with atrophy, was evident on both visual inspection and quantitative cortical surface-based analysis. Five patients were amyloid negative, one was amyloid positive and one has an unknown amyloid status. In this series of patients with clinical profiles, structural MRI and amyloid PET imaging typical for svPPA, FTP signal was unexpectedly elevated with a spatial pattern localised to areas of atrophy. This raises questions about the possible off-target binding of this tracer to non-tau molecules associated with neurodegeneration. Further investigation with autopsy analysis will help illuminate the binding target(s) of FTP in cases of suspected FTLD-TDP neuropathology. ObjectiveThe semantic variant of primary progressive aphasia (svPPA) is typically associated with frontotemporal lobar degeneration (FTLD) with longTAR DNA-binding protein (TDP)-43-positive neuropil threads and dystrophic neurites (type C), and is only rarely due to a primary tauopathy or Alzheimer’s disease. We undertook this study to investigate the localisation and magnitude of the presumed tau Positron Emission Tomography (PET) tracer [18F]Flortaucipir (FTP; also known as T807 or AV1451) in patients with svPPA, hypothesising that most patients would not show tracer uptake different from controls.MethodsFTP and [11C]Pittsburgh compound B PET imaging as well as MRI were performed in seven patients with svPPA and in 20 controls. FTP signal was analysed by visual inspection and by quantitative comparison to controls, with and without partial volume correction.ResultsAll seven patients showed elevated FTP uptake in the anterior temporal lobe with a leftward asymmetry that was not observed in healthy controls. This elevated FTP signal, largely co-localised with atrophy, was evident on both visual inspection and quantitative cortical surface-based analysis. Five patients were amyloid negative, one was amyloid positive and one has an unknown amyloid status.ConclusionsIn this series of patients with clinical profiles, structural MRI and amyloid PET imaging typical for svPPA, FTP signal was unexpectedly elevated with a spatial pattern localised to areas of atrophy. This raises questions about the possible off-target binding of this tracer to non-tau molecules associated with neurodegeneration. Further investigation with autopsy analysis will help illuminate the binding target(s) of FTP in cases of suspected FTLD-TDP neuropathology. |
Author | Makaretz, Sara J Dickerson, Bradford C Johnson, Keith A Collins, Jessica McGinnis, Scott Schultz, Aaron Vasdev, Neil Quimby, Megan Makris, Nikos |
AuthorAffiliation | 1 Frontotemporal Disorders Unit, Department of Neurology , Massachusetts General Hospital and Harvard Medical School , Charlestown , Massachusetts , USA 5 Alzheimer’s Disease Research Center, Department of Neurology , Massachusetts General Hospital and Harvard Medical School , Boston , Massachusetts , USA 3 Center for Alzheimer Research and Treatment, Department of Neurology , Brigham and Women’s Hospital , Boston , Massachusetts , USA 2 Center for Morphometric Analysis, Department of Psychiatry , Massachusetts General Hospital and Harvard Medical School , Charlestown , Massachusetts , USA 6 Division of Nuclear Medicine and Molecular Imaging, Department of Radiology , Massachusetts General Hospital and Harvard Medical School , Boston , Massachusetts , USA 4 Martinos Center for Biomedical Imaging , Massachusetts General Hospital and Harvard Medical School , Charlestown , Massachusetts , USA |
AuthorAffiliation_xml | – name: 1 Frontotemporal Disorders Unit, Department of Neurology , Massachusetts General Hospital and Harvard Medical School , Charlestown , Massachusetts , USA – name: 4 Martinos Center for Biomedical Imaging , Massachusetts General Hospital and Harvard Medical School , Charlestown , Massachusetts , USA – name: 6 Division of Nuclear Medicine and Molecular Imaging, Department of Radiology , Massachusetts General Hospital and Harvard Medical School , Boston , Massachusetts , USA – name: 2 Center for Morphometric Analysis, Department of Psychiatry , Massachusetts General Hospital and Harvard Medical School , Charlestown , Massachusetts , USA – name: 5 Alzheimer’s Disease Research Center, Department of Neurology , Massachusetts General Hospital and Harvard Medical School , Boston , Massachusetts , USA – name: 3 Center for Alzheimer Research and Treatment, Department of Neurology , Brigham and Women’s Hospital , Boston , Massachusetts , USA |
Author_xml | – sequence: 1 givenname: Sara J surname: Makaretz fullname: Makaretz, Sara J email: brad.dickerson@mgh.harvard.edu organization: Frontotemporal Disorders Unit, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, USA – sequence: 2 givenname: Megan surname: Quimby fullname: Quimby, Megan email: brad.dickerson@mgh.harvard.edu organization: Frontotemporal Disorders Unit, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, USA – sequence: 3 givenname: Jessica surname: Collins fullname: Collins, Jessica email: brad.dickerson@mgh.harvard.edu organization: Frontotemporal Disorders Unit, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, USA – sequence: 4 givenname: Nikos surname: Makris fullname: Makris, Nikos email: brad.dickerson@mgh.harvard.edu organization: Center for Morphometric Analysis, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, USA – sequence: 5 givenname: Scott surname: McGinnis fullname: McGinnis, Scott email: brad.dickerson@mgh.harvard.edu organization: Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women’s Hospital, Boston, Massachusetts, USA – sequence: 6 givenname: Aaron surname: Schultz fullname: Schultz, Aaron email: brad.dickerson@mgh.harvard.edu organization: Alzheimer’s Disease Research Center, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA – sequence: 7 givenname: Neil surname: Vasdev fullname: Vasdev, Neil email: brad.dickerson@mgh.harvard.edu organization: Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA – sequence: 8 givenname: Keith A surname: Johnson fullname: Johnson, Keith A email: brad.dickerson@mgh.harvard.edu organization: Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA – sequence: 9 givenname: Bradford C surname: Dickerson fullname: Dickerson, Bradford C email: brad.dickerson@mgh.harvard.edu organization: Alzheimer’s Disease Research Center, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28986472$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUU1rGzEUFCUlcdLeeyoLvQTCtvr-uBSCcdKCITmk0JvQrrW2zK60lXYN-ffRYqckPiS6PIk3M2_05hyc-OAtAF8Q_I4Q4T-23vclhkiUBHEK1QcwQ5TLkhD49wTMIMS4JJDBM3Ce0hZOR6pTcIalkpwKPAPLmzbEwYy1610s8qW4XzwUrjNr59eF80WynfGDq4udiS7fij7mbnzMNayjTcntbGH6jUnOfAIfG9Mm-_lQL8Cfm8XD_Fe5vLv9Pb9elhXDfCiJII1ApKGUSpJ9rKAxihO5EsZAuKqkJUIIjAhlrFEc5qeqFJaCMa5oQ8gF-LnX7ceqs6va-iGaVh-c6WCcft3xbqPXYaeZyluiLAtcHgRi-DfaNOjOpdq2rfE2jEkjRfM0ReQ069sRdBvG6PP3NEaIIQoFoRn19aWj_1aeF50BfA-oY0gp2kbXbjCDC5NB12oE9ZSonhLVU6J6n2gmwiPis_YblKs9peq276OfACo9sIw |
CitedBy_id | crossref_primary_10_1007_s00259_021_05401_4 crossref_primary_10_1093_brain_awab392 crossref_primary_10_2217_nmt_2017_0057 crossref_primary_10_1001_jamaneurol_2023_2560 crossref_primary_10_3389_fneur_2018_00070 crossref_primary_10_1212_WNL_0000000000005112 crossref_primary_10_1007_s00259_022_05963_x crossref_primary_10_1016_j_jalz_2018_02_018 crossref_primary_10_1016_j_nicl_2019_101889 crossref_primary_10_1016_j_neurobiolaging_2018_02_015 crossref_primary_10_1007_s00259_018_4075_3 crossref_primary_10_1007_s00259_019_04631_x crossref_primary_10_1016_j_neurobiolaging_2018_11_017 crossref_primary_10_1016_j_arr_2024_102375 crossref_primary_10_1136_jnnp_2019_322402 crossref_primary_10_1002_acn3_683 crossref_primary_10_1186_s13195_023_01176_y crossref_primary_10_1097_WCO_0000000000001035 crossref_primary_10_1001_jamaneurol_2019_4284 crossref_primary_10_1002_ana_26479 crossref_primary_10_1016_j_praneu_2021_03_011 crossref_primary_10_1093_braincomms_fcae075 crossref_primary_10_1016_S1474_4422_21_00341_0 crossref_primary_10_3390_brainsci12020146 crossref_primary_10_1007_s00259_022_06065_4 crossref_primary_10_1186_s13195_019_0470_7 crossref_primary_10_1093_braincomms_fcad305 crossref_primary_10_1016_j_ncl_2019_08_003 crossref_primary_10_1212_WNL_0000000000006913 crossref_primary_10_1016_j_imu_2024_101551 crossref_primary_10_1002_dad2_12348 crossref_primary_10_3390_ijms232112867 crossref_primary_10_1093_brain_awab057 crossref_primary_10_3390_diagnostics13162687 crossref_primary_10_1007_s11604_019_00881_9 crossref_primary_10_1186_s13195_019_0483_2 crossref_primary_10_1007_s00415_020_10040_0 crossref_primary_10_1055_s_0040_1715134 crossref_primary_10_2967_jnumed_120_244061 crossref_primary_10_1109_ACCESS_2020_2989396 crossref_primary_10_1016_j_jalz_2019_02_004 crossref_primary_10_1038_s41598_019_42625_9 crossref_primary_10_1016_j_nicl_2020_102369 crossref_primary_10_1001_jamaneurol_2020_0989 crossref_primary_10_3390_brainsci11040433 crossref_primary_10_1002_alz_12356 crossref_primary_10_1016_j_cortex_2022_05_010 crossref_primary_10_3389_fneur_2020_00080 crossref_primary_10_1126_scitranslmed_aaw1993 crossref_primary_10_1007_s11277_024_10920_y crossref_primary_10_3389_fnins_2024_1342928 crossref_primary_10_17340_jkna_2019_1_1 crossref_primary_10_3390_brainsci12070843 crossref_primary_10_1093_brain_awaa276 crossref_primary_10_14412_2074_2711_2019_1_4_11 crossref_primary_10_31363_2313_7053_2024_853 crossref_primary_10_1093_brain_awaa033 crossref_primary_10_12688_f1000research_20330_1 crossref_primary_10_1016_j_neurobiolaging_2020_04_010 crossref_primary_10_1111_ene_15603 crossref_primary_10_1002_ana_25183 crossref_primary_10_1053_j_semnuclmed_2020_12_004 crossref_primary_10_1016_j_neuropsychologia_2020_107391 crossref_primary_10_1007_s00401_024_02801_2 crossref_primary_10_1007_s00415_019_09530_7 crossref_primary_10_1007_s00415_018_8815_x crossref_primary_10_1007_s13311_021_01101_x crossref_primary_10_1097_WCO_0000000000000792 crossref_primary_10_3389_fnins_2018_00585 crossref_primary_10_3389_fnagi_2018_00230 crossref_primary_10_1016_j_neuron_2019_08_037 crossref_primary_10_1093_brain_awaa383 crossref_primary_10_1212_CON_0000000000001506 |
Cites_doi | 10.1038/srep16404 10.1002/ana.24885 10.1093/cercor/bhg087 10.1212/WNL.0b013e3181ea15e8 10.1007/s00401-013-1089-6 10.1007/s00401-011-0845-8 10.1177/0271678X16683695 10.1212/WNL.0b013e31821103e6 10.1002/ana.24844 10.2967/jnumed.116.175273 10.1136/jnnp-2013-306948 10.1186/s13195-017-0253-y 10.1002/ana.24517 10.1093/brain/aww313 10.1001/jamaneurol.2016.5755 10.1016/j.jalz.2016.01.003 10.1056/NEJMra022435 10.1093/brain/awp248 10.1016/j.neuroimage.2016.02.042 10.1056/NEJMcpc1613459 10.1007/s00401-016-1618-1 10.1093/brain/aww027 10.1016/j.neuropsychologia.2009.04.011 10.1093/brain/aww163 10.1093/brain/awm213 10.1186/s40478-016-0315-6 10.1002/ana.24546 10.2967/jnumed.115.170027 10.1007/s00401-012-1055-8 10.1007/s00401-008-0460-5 10.1212/WNL.0000000000000431 10.1001/jamaneurol.2016.3338 10.1016/j.neuron.2016.01.028 10.1097/WAD.0b013e31824a7df4 10.1016/j.neuroimage.2006.01.021 10.1002/jlcr.3098 10.1093/brain/115.6.1783 |
ContentType | Journal Article |
Copyright | Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. 2018 Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. 2018 |
Copyright_xml | – notice: Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. – notice: 2018 Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. 2018 |
DBID | 9YT ACMMV AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 88G 88I 8AF 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR BTHHO CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. KB0 M0S M1P M2M M2P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 5PM |
DOI | 10.1136/jnnp-2017-316409 |
DatabaseName | BMJ Open Access Journals BMJ Journals:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) Science Database (Alumni Edition) STEM Database ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central BMJ Journals ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database Psychology Database Science Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition BMJ Journals ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest One Psychology |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: ACMMV name: BMJ Journals:Open Access url: https://journals.bmj.com/ sourceTypes: Publisher – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1468-330X |
EndPage | 1031 |
ExternalDocumentID | PMC5964045 28986472 10_1136_jnnp_2017_316409 jnnp |
Genre | Journal Article Research Support, N.I.H., Extramural |
GeographicLocations | United States--US Pittsburgh Pennsylvania |
GeographicLocations_xml | – name: United States--US – name: Pittsburgh Pennsylvania |
GrantInformation_xml | – fundername: NIA NIH HHS grantid: P30 AG062421 – fundername: NIA NIH HHS grantid: P01 AG036694 – fundername: NIA NIH HHS grantid: P50 AG005134 – fundername: NINDS NIH HHS grantid: R21 NS077059 – fundername: NIA NIH HHS grantid: R01 AG046396 – fundername: NIA NIH HHS grantid: R21 AG051987 – fundername: NIBIB NIH HHS grantid: P41 EB015896 – fundername: NCRR NIH HHS grantid: S10 RR023043 – fundername: NIDCD NIH HHS grantid: R01 DC014296 – fundername: NCRR NIH HHS grantid: S10 RR021110 – fundername: ; |
GroupedDBID | --- .55 .GJ .VT 0R~ 18M 29L 2WC 354 39C 3O- 4.4 40O 41~ 53G 5GY 5RE 5VS 7RV 7X7 7~S 88E 88I 8AF 8FI 8FJ 8R4 8R5 9YT AAHLL AAKAS AAOJX AAUVZ AAWJN AAWTL ABAAH ABIVO ABJNI ABKDF ABMQD ABOCM ABUWG ABVAJ ACGFO ACGFS ACGOD ACGTL ACHTP ACMFJ ACMMV ACOAB ACOFX ACQSR ACTZY ADBBV ADCEG ADFRT ADUGQ ADZCM AEKJL AENEX AFKRA AFWFF AGQPQ AHMBA AHNKE AHQMW AI. AJYBZ AKKEP ALIPV ALMA_UNASSIGNED_HOLDINGS AZFZN AZQEC BAWUL BENPR BLJBA BOMFT BPHCQ BTFSW BTHHO BVXVI C45 CAG CCPQU COF CS3 CXRWF DIK DU5 DWQXO E3Z EBS EJD EX3 F5P FEDTE FYUFA GNUQQ GX1 H13 HAJ HCIFZ HMCUK HVGLF HYE HZ~ IAO IEA IHR INH INR IOF IPO IPY ITC J5H KQ8 L7B M1P M2M M2P N9A NAPCQ NTWIH NXWIF O9- OK1 OMB OMG OVD P2P PCD PHGZT PQQKQ PROAC PSQYO PSYQQ Q2X R53 RHI RMJ RPM RV8 SJN TEORI TR2 UKHRP UPT UYXKK V24 VH1 VM9 VVN W8F WH7 WOW X7M YFH YQT YQY ZGI AAYXX ACQHZ ADGHP AERUA CITATION PHGZM 3V. CGR CUY CVF ECM EIF NPM PKN RHF YCJ 7XB 8FK K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-b526t-373f713f44483864d0aa9638d7aa00db8e3777213455f960e379b928755694f33 |
IEDL.DBID | 9YT |
ISSN | 0022-3050 1468-330X |
IngestDate | Thu Aug 21 18:12:53 EDT 2025 Fri Jul 11 16:49:03 EDT 2025 Fri Jul 25 22:15:17 EDT 2025 Wed Feb 19 02:30:16 EST 2025 Thu Apr 24 22:56:41 EDT 2025 Tue Jul 01 01:21:40 EDT 2025 Thu Apr 24 23:06:45 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | temporallobe semantic dementia brain atrophy primary progressive aphasia tau PET |
Language | English |
License | This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0 Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b526t-373f713f44483864d0aa9638d7aa00db8e3777213455f960e379b928755694f33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | http://dx.doi.org/10.1136/jnnp-2017-316409 |
PMID | 28986472 |
PQID | 2115140734 |
PQPubID | 2041879 |
PageCount | 8 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5964045 proquest_miscellaneous_1948759383 proquest_journals_2115140734 pubmed_primary_28986472 crossref_citationtrail_10_1136_jnnp_2017_316409 crossref_primary_10_1136_jnnp_2017_316409 bmj_primary_10_1136_jnnp_2017_316409 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-10-01 |
PublicationDateYYYYMMDD | 2018-10-01 |
PublicationDate_xml | – month: 10 year: 2018 text: 2018-10-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London – name: BMA House, Tavistock Square, London, WC1H 9JR |
PublicationSeriesTitle | Research paper |
PublicationTitle | Journal of neurology, neurosurgery and psychiatry |
PublicationTitleAlternate | J Neurol Neurosurg Psychiatry |
PublicationYear | 2018 |
Publisher | BMJ Publishing Group LTD BMJ Publishing Group |
Publisher_xml | – name: BMJ Publishing Group LTD – name: BMJ Publishing Group |
References | Shoup, Yokell, Rice 2013 Schöll, Carter, Westman 2015; 5 Shcherbinin, Schwarz, Joshi 2016; 57 Marquié, Normandin, Vanderburg 2015; 78 Robinson, Geser, Stieber 2013; 125 Sapolsky, Bakkour, Negreira 2010; 75 Greve, Salat, Bowen 2016; 132 Josephs, Whitwell, Tacik 2016; 132 Mackenzie, Neumann, Bigio 2009; 117 Xia, Makaretz, Caso 2017; 74 Fischl, van der Kouwe, Destrieux 2004; 14 Mesulam, Dickerson, Sherman 2017; 376 Johnson, Schultz, Betensky 2016; 79 Mesulam 2003; 349 Ng, Pascoal, Mathotaarachchi 2017; 9 Halabi, Halabi, Dean 2013; 27 Spinelli, Mandelli, Miller 2017; 81 Desikan, Ségonne, Fischl 2006; 31 Ossenkoppele, Schonhaut, Schöll 2016; 139 Gorno-Tempini, Hillis, Weintraub 2011; 76 Marquié, Normandin, Meltzer 2017; 81 Schöll, Lockhart, Schonhaut 2016; 89 Coakeley, Cho, Koshimori 2016; 271678X Sander, Lashley, Gami 2016; 12 Hodges, Patterson, Oxbury 1992; 115 Smith, Puschmann, Schöll 2016; 139 Baker, Lockhart, Price 2017; 58 Crawford, Garthwaite, Howell 2009; 47 Alladi, Xuereb, Bak 2007; 130 Collins, Montal, Hochberg 2017; 140 Lowe, Curran, Fang 2016; 4 Chare, Hodges, Leyton 2014; 85 Mormino, Betensky, Hedden 2014; 82 Mackenzie, Neumann, Baborie 2011; 122 Gomperts, Locascio, Makaretz 2016; 73 Hodges, Mitchell, Dawson 2010; 133 Bigio, Wu, Deng 2013; 125 2020050722281760000_89.10.1024.35 Josephs (2020050722281760000_89.10.1024.12) 2016; 132 2020050722281760000_89.10.1024.14 Sander (2020050722281760000_89.10.1024.17) 2016; 12 2020050722281760000_89.10.1024.37 2020050722281760000_89.10.1024.18 Ng (2020050722281760000_89.10.1024.36) 2017; 9 Coakeley (2020050722281760000_89.10.1024.13) 2016; 271678X Mesulam (2020050722281760000_89.10.1024.3) 2017; 376 Marquié (2020050722281760000_89.10.1024.15) 2017; 81 2020050722281760000_89.10.1024.7 2020050722281760000_89.10.1024.6 2020050722281760000_89.10.1024.9 2020050722281760000_89.10.1024.8 2020050722281760000_89.10.1024.2 2020050722281760000_89.10.1024.5 2020050722281760000_89.10.1024.4 2020050722281760000_89.10.1024.30 2020050722281760000_89.10.1024.31 2020050722281760000_89.10.1024.32 2020050722281760000_89.10.1024.1 2020050722281760000_89.10.1024.11 2020050722281760000_89.10.1024.33 2020050722281760000_89.10.1024.24 2020050722281760000_89.10.1024.25 2020050722281760000_89.10.1024.26 2020050722281760000_89.10.1024.27 2020050722281760000_89.10.1024.28 2020050722281760000_89.10.1024.29 Lowe (2020050722281760000_89.10.1024.16) 2016; 4 Xia (2020050722281760000_89.10.1024.19) 2017; 74 Gomperts (2020050722281760000_89.10.1024.34) 2016; 73 2020050722281760000_89.10.1024.20 2020050722281760000_89.10.1024.21 Spinelli (2020050722281760000_89.10.1024.10) 2017; 81 2020050722281760000_89.10.1024.22 2020050722281760000_89.10.1024.23 |
References_xml | – volume: 5 start-page: 16404 year: 2015 article-title: Early astrocytosis in autosomal dominant Alzheimer’s disease measured in vivo by multi-tracer positron emission tomography publication-title: Sci Rep doi: 10.1038/srep16404 – volume: 81 start-page: 430 year: 2017 article-title: Typical and atypical pathology in primary progressive aphasia variants publication-title: Ann Neurol doi: 10.1002/ana.24885 – volume: 14 start-page: 11 year: 2004 article-title: Automatically parcellating the human cerebral cortex publication-title: Cereb Cortex doi: 10.1093/cercor/bhg087 – volume: 75 start-page: 358 year: 2010 article-title: Cortical neuroanatomic correlates of symptom severity in primary progressive aphasia publication-title: Neurology doi: 10.1212/WNL.0b013e3181ea15e8 – volume: 125 start-page: 463 year: 2013 article-title: Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid publication-title: Acta Neuropathol doi: 10.1007/s00401-013-1089-6 – volume: 122 start-page: 111 year: 2011 article-title: A harmonized classification system for FTLD-TDP pathology publication-title: Acta Neuropathol doi: 10.1007/s00401-011-0845-8 – volume: 271678X start-page: 0271678X1668369 year: 2016 article-title: Positron emission tomography imaging of tau pathology in progressive supranuclear palsy publication-title: J Cereb Blood Flow Metab doi: 10.1177/0271678X16683695 – volume: 76 start-page: 1006 year: 2011 article-title: Classification of primary progressive aphasia and its variants publication-title: Neurology doi: 10.1212/WNL.0b013e31821103e6 – volume: 81 start-page: 117 year: 2017 article-title: Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies publication-title: Ann Neurol doi: 10.1002/ana.24844 – volume: 58 start-page: 332 year: 2017 article-title: Reference Tissue-Based kinetic evaluation of 18F-AV-1451 for Tau Imaging publication-title: J Nucl Med doi: 10.2967/jnumed.116.175273 – volume: 85 start-page: 865 year: 2014 article-title: New criteria for frontotemporal dementia syndromes: clinical and pathological diagnostic implications publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp-2013-306948 – volume: 9 start-page: 25 year: 2017 article-title: Monoamine oxidase B inhibitor, selegiline, reduces (18)F-THK5351 uptake in the human brain publication-title: Alzheimers Res Ther doi: 10.1186/s13195-017-0253-y – volume: 78 start-page: 787 year: 2015 article-title: Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue publication-title: Ann Neurol doi: 10.1002/ana.24517 – volume: 140 start-page: 457 year: 2017 article-title: Focal temporal pole atrophy and network degeneration in semantic variant primary progressive aphasia publication-title: Brain doi: 10.1093/brain/aww313 – volume: 115 start-page: 1783 issue: Pt 6 year: 1992 article-title: Semantic dementia. progressive fluent aphasia with temporal lobe atrophy publication-title: Brain – volume: 74 start-page: 427 year: 2017 article-title: Association of In Vivo [18F]AV-1451 tau PET Imaging results with cortical atrophy and symptoms in typical and atypical alzheimer disease publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2016.5755 – volume: 12 start-page: 1116 year: 2016 article-title: Characterization of tau positron emission tomography tracer [(18)F]AV-1451 binding to postmortem tissue in Alzheimer’s disease, primary tauopathies, and other dementias publication-title: Alzheimers Dement doi: 10.1016/j.jalz.2016.01.003 – volume: 349 start-page: 1535 year: 2003 article-title: Primary progressive aphasia--a language-based dementia publication-title: N Engl J Med doi: 10.1056/NEJMra022435 – volume: 133 start-page: 300 year: 2010 article-title: Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases publication-title: Brain doi: 10.1093/brain/awp248 – volume: 132 start-page: 334 year: 2016 article-title: Different partial volume correction methods lead to different conclusions: an (18)F-FDG-PET study of aging publication-title: Neuroimage doi: 10.1016/j.neuroimage.2016.02.042 – volume: 376 start-page: 158 year: 2017 article-title: Case 1-2017. A 70-Year-Old Woman with gradually progressive loss of language publication-title: N Engl J Med doi: 10.1056/NEJMcpc1613459 – volume: 132 start-page: 931 year: 2016 article-title: [18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degeneration publication-title: Acta Neuropathol doi: 10.1007/s00401-016-1618-1 – volume: 139 start-page: 1551 year: 2016 article-title: Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease publication-title: Brain doi: 10.1093/brain/aww027 – volume: 47 start-page: 2690 year: 2009 article-title: On comparing a single case with a control sample: an alternative perspective publication-title: Neuropsychologia doi: 10.1016/j.neuropsychologia.2009.04.011 – volume: 139 start-page: 2372 year: 2016 article-title: 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers publication-title: Brain doi: 10.1093/brain/aww163 – volume: 130 start-page: 2636 year: 2007 article-title: Focal cortical presentations of Alzheimer’s disease publication-title: Brain doi: 10.1093/brain/awm213 – volume: 4 start-page: 58 year: 2016 article-title: An autoradiographic evaluation of AV-1451 Tau PET in dementia publication-title: Acta Neuropathol Commun doi: 10.1186/s40478-016-0315-6 – volume: 79 start-page: 110 year: 2016 article-title: Tau positron emission tomographic imaging in aging and early alzheimer disease publication-title: Ann Neurol doi: 10.1002/ana.24546 – volume: 57 start-page: 1535 year: 2016 article-title: Kinetics of the Tau PET Tracer 18F-AV-1451 (T807) in subjects with normal cognitive function, mild cognitive impairment, and Alzheimer Disease publication-title: J Nucl Med doi: 10.2967/jnumed.115.170027 – year: 2013 article-title: A concise radiosynthesis of the tau radiopharmaceutical, [18F]T807 publication-title: J Label Compd Radiopharm – volume: 125 start-page: 121 year: 2013 article-title: TDP-43 skeins show properties of amyloid in a subset of ALS cases publication-title: Acta Neuropathol doi: 10.1007/s00401-012-1055-8 – volume: 117 start-page: 15 year: 2009 article-title: Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations publication-title: Acta Neuropathol doi: 10.1007/s00401-008-0460-5 – volume: 82 start-page: 1760 year: 2014 article-title: Amyloid and APOE ε4 interact to influence short-term decline in preclinical alzheimer disease publication-title: Neurology doi: 10.1212/WNL.0000000000000431 – volume: 73 start-page: 1334 year: 2016 article-title: Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2016.3338 – volume: 89 start-page: 971 year: 2016 article-title: PET Imaging of Tau Deposition in the Aging Human brain publication-title: Neuron doi: 10.1016/j.neuron.2016.01.028 – volume: 27 start-page: 74 year: 2013 article-title: Patterns of striatal degeneration in frontotemporal dementia publication-title: Alzheimer Dis Assoc Disord doi: 10.1097/WAD.0b013e31824a7df4 – volume: 31 start-page: 968 year: 2006 article-title: An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest publication-title: Neuroimage doi: 10.1016/j.neuroimage.2006.01.021 – volume: 9 start-page: 25 year: 2017 ident: 2020050722281760000_89.10.1024.36 article-title: Monoamine oxidase B inhibitor, selegiline, reduces (18)F-THK5351 uptake in the human brain publication-title: Alzheimers Res Ther doi: 10.1186/s13195-017-0253-y – ident: 2020050722281760000_89.10.1024.2 doi: 10.1212/WNL.0b013e31821103e6 – ident: 2020050722281760000_89.10.1024.26 doi: 10.1016/j.neuroimage.2016.02.042 – ident: 2020050722281760000_89.10.1024.30 doi: 10.2967/jnumed.115.170027 – volume: 132 start-page: 931 year: 2016 ident: 2020050722281760000_89.10.1024.12 article-title: [18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degeneration publication-title: Acta Neuropathol doi: 10.1007/s00401-016-1618-1 – volume: 81 start-page: 117 year: 2017 ident: 2020050722281760000_89.10.1024.15 article-title: Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies publication-title: Ann Neurol doi: 10.1002/ana.24844 – ident: 2020050722281760000_89.10.1024.24 doi: 10.1002/jlcr.3098 – ident: 2020050722281760000_89.10.1024.25 doi: 10.2967/jnumed.116.175273 – ident: 2020050722281760000_89.10.1024.29 doi: 10.1002/ana.24546 – ident: 2020050722281760000_89.10.1024.27 doi: 10.1016/j.neuroimage.2006.01.021 – ident: 2020050722281760000_89.10.1024.6 doi: 10.1007/s00401-008-0460-5 – ident: 2020050722281760000_89.10.1024.8 doi: 10.1093/brain/awp248 – ident: 2020050722281760000_89.10.1024.11 doi: 10.1093/brain/aww163 – ident: 2020050722281760000_89.10.1024.20 doi: 10.1212/WNL.0b013e3181ea15e8 – ident: 2020050722281760000_89.10.1024.1 doi: 10.1093/brain/aww313 – ident: 2020050722281760000_89.10.1024.31 doi: 10.1007/s00401-013-1089-6 – volume: 376 start-page: 158 year: 2017 ident: 2020050722281760000_89.10.1024.3 article-title: Case 1-2017. A 70-Year-Old Woman with gradually progressive loss of language publication-title: N Engl J Med doi: 10.1056/NEJMcpc1613459 – ident: 2020050722281760000_89.10.1024.22 doi: 10.1212/WNL.0000000000000431 – ident: 2020050722281760000_89.10.1024.9 doi: 10.1136/jnnp-2013-306948 – ident: 2020050722281760000_89.10.1024.21 doi: 10.1056/NEJMra022435 – ident: 2020050722281760000_89.10.1024.37 doi: 10.1038/srep16404 – ident: 2020050722281760000_89.10.1024.35 doi: 10.1097/WAD.0b013e31824a7df4 – volume: 81 start-page: 430 year: 2017 ident: 2020050722281760000_89.10.1024.10 article-title: Typical and atypical pathology in primary progressive aphasia variants publication-title: Ann Neurol doi: 10.1002/ana.24885 – volume: 4 start-page: 58 year: 2016 ident: 2020050722281760000_89.10.1024.16 article-title: An autoradiographic evaluation of AV-1451 Tau PET in dementia publication-title: Acta Neuropathol Commun doi: 10.1186/s40478-016-0315-6 – ident: 2020050722281760000_89.10.1024.18 doi: 10.1093/brain/aww027 – volume: 74 start-page: 427 year: 2017 ident: 2020050722281760000_89.10.1024.19 article-title: Association of In Vivo [18F]AV-1451 tau PET Imaging results with cortical atrophy and symptoms in typical and atypical alzheimer disease publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2016.5755 – volume: 73 start-page: 1334 year: 2016 ident: 2020050722281760000_89.10.1024.34 article-title: Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2016.3338 – ident: 2020050722281760000_89.10.1024.23 doi: 10.1093/cercor/bhg087 – ident: 2020050722281760000_89.10.1024.5 doi: 10.1007/s00401-011-0845-8 – volume: 12 start-page: 1116 year: 2016 ident: 2020050722281760000_89.10.1024.17 article-title: Characterization of tau positron emission tomography tracer [(18)F]AV-1451 binding to postmortem tissue in Alzheimer’s disease, primary tauopathies, and other dementias publication-title: Alzheimers Dement doi: 10.1016/j.jalz.2016.01.003 – ident: 2020050722281760000_89.10.1024.33 doi: 10.1016/j.neuron.2016.01.028 – ident: 2020050722281760000_89.10.1024.28 doi: 10.1016/j.neuropsychologia.2009.04.011 – ident: 2020050722281760000_89.10.1024.4 doi: 10.1093/brain/115.6.1783 – ident: 2020050722281760000_89.10.1024.32 doi: 10.1007/s00401-012-1055-8 – volume: 271678X start-page: 0271678X1668369 year: 2016 ident: 2020050722281760000_89.10.1024.13 article-title: Positron emission tomography imaging of tau pathology in progressive supranuclear palsy publication-title: J Cereb Blood Flow Metab – ident: 2020050722281760000_89.10.1024.7 doi: 10.1093/brain/awm213 – ident: 2020050722281760000_89.10.1024.14 doi: 10.1002/ana.24517 |
SSID | ssj0000089 |
Score | 2.5157657 |
Snippet | ObjectiveThe semantic variant of primary progressive aphasia (svPPA) is typically associated with frontotemporal lobar degeneration (FTLD) with longTAR... The semantic variant of primary progressive aphasia (svPPA) is typically associated with frontotemporal lobar degeneration (FTLD) with longTAR DNA-binding... |
SourceID | pubmedcentral proquest pubmed crossref bmj |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1024 |
SubjectTerms | Age Aged Aged, 80 and over Aging Amyotrophic lateral sclerosis Aphasia Aphasia, Primary Progressive - diagnostic imaging Aphasia, Primary Progressive - metabolism Atrophy Brain Brain - diagnostic imaging Brain - metabolism Carbolines Dementia Disease Female Humans Language Magnetic Resonance Imaging Male Medical imaging Middle Aged Neurodegeneration Neuroimaging Neuropathology NMR Nuclear magnetic resonance Pathology Patients Positron-Emission Tomography - methods Semantics tau Proteins - metabolism |
SummonAdditionalLinks | – databaseName: ProQuest Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3db9QwDLfYkBAviO8VBgrSXnioLm0-mjwhhHaaECAeNuneorRNtU67Xtnd7e_HbnNlB9J4S9WmTW0n8c92bIATXRaFD5VNjdEilVnJUx9MMxzOkaZqSl4P0RY_9NmF_LpQi2hwW8ewyt2aOCzU9aoiG_kMgQru7SiQ8lP_K6WqUeRdjSU0DuAhpS4j8FUsijvqr7FTtnCu-M5NKfTsqut6lJCMjHRaUjjiQbm82t-c_tE4_w6cvLMTzZ_Ck6hCss8jz5_Bg9A9h0ffo5P8BXybX5NOva3avr1h2GA_T89ZuxzqEbG2Y-uwRHq2FbtFoIwt1o8pJ9gQrEVxsbeB-f6SDli-hIv56fmXszQWTUhLlesNLhiiQeDZSMRdwmhZc-9pktWF95zXpQmiQI06E1KpBuELXtrSIm5SSlvZCPEKDrtVF46A8bxSuQw8D4WRxlubZ3WgFG0ir42sdQInSDMXx-gGOCG0I9I6Iq0bSZvAbEdUV8XE41T_4vqeHh-nHv9_-_GOTy5Ov7X7IywJfJhu48Qhb4jvwmq7dpklrGYRoSfwemTr9DFEoYby6idQ7DF8eoCScu_f6drLITm3sjgqqd7cP6y38Bj_wYy2nGM43NxswzvUbjbl-0GEfwNvEPS0 priority: 102 providerName: ProQuest |
Title | Flortaucipir tau PET imaging in semantic variant primary progressive aphasia |
URI | https://jnnp.bmj.com/content/89/10/1024.full https://www.ncbi.nlm.nih.gov/pubmed/28986472 https://www.proquest.com/docview/2115140734 https://www.proquest.com/docview/1948759383 https://pubmed.ncbi.nlm.nih.gov/PMC5964045 |
Volume | 89 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LT9wwEB4VkKpeKvpOoStX4tJDhBM_Yh8p2hVCXYSqpdqerDwcEcSGFbvL7-9Mkk1ZigqnOHLsODN-zJcZfwY40FmSpD63oTFahDLKeJh6Uzabc6TJy4wXTbTFmT65kKdTNf1Lk_PAgx8JfXhV13PUZUS_07SkvXo7RMlCQMv-ntwzdY3tmcG54muX5CM1EAGwIVpyogXeymZXm2vSP4bmw3jJewvQaBded5YjO2pV_QZe-PotvBx3vvF38GN0Tab0Kq_m1S3DBDsfTlg1a44hYlXNFn6GYqxydof4GFNs3jJNsCZGi8Jh7zxL55e0r_I9XIyGk-OTsDsrIcxUrJc4T4gS8WYpEW4J_LSCpymNrSJJU86LzHiRoCEdCalUiagFb21mES4ppa0shfgA2_VN7T8B43GuYul57BMjTWptHBWemNlEXBhZ6AAOUGaua6NrUITQjqTsSMqulXIAh2uhurzjG6djL67_U-JbX-Lp2vfXenLdqFs4BLNo_-GkJQP42mfjeCEnSFr7m9XCRZYgmkVgHsDHVq39y9a9IoBkQ-H9A8TFvZlTV5cNJ7ey2CqpPj9PNnvwCu9aXt1oH7aXtyv_BY2bZTaArWSaDJq-PYCdo-Px-Bdevw_Pzn_-AQIQ8iQ |
linkProvider | BMJ Publishing Group Ltd |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkaAXxLMNtGCkcuAQrRM_Yh8QQqWrLd1WHLbS3kwejpqqmw3d3SL-FL-RmbzoglROvTlKnDjzsOfzjGcI2VdJFMUuNb7WivsiSJgfO53Xh3OETvOEZXW0xakanYkvUzndIL-6szAYVtnNifVEnc1T3CMfAFCBtR0EUnysvvtYNQq9q10JjUYsjt3PHwDZFh-OPgN_34Xh8HByMPLbqgJ-IkO1BI3iOSCzXAAw4VqJjMUxSmEWxTFjWaIdj8DkDLiQMgf7Hi5NYgBYSKmMyHEDFKb8-7DwMgwhjKbRDXNbmz47OZOsc4tyNbgoywokMsBNQSUw_PFeMrtYXwz_sXD_DtS8sfINH5NHrclKPzUy9oRsuPIpeXDSOuWfkfHwEm34VVpUxRWFBv16OKHFrK5_RIuSLtwM-Fek9BqAObRo1aS4oHVwGMbhXjsaV-d4oPM5ObsTcr4gm-W8dDuEsjCVoXAsdJEWOjYmDDKHKeF4mGmRKY_sA81sO0ZbwxeuLJLWImltQ1qPDDqi2rRNdI71Ni5v6fG-7_H_t-92fLKtui_sH-H0yNv-Nigqel_i0s1XCxsYxIaGa-6R7Yat_ccA9WrM4--RaI3h_QOYBHz9Tlmc18nApYFRCfny9mG9IQ9Hk5OxHR-dHr8iW_A_TVLfYJdsLq9Wbg8sq2XyuhZnSr7dtf78Bt4eLkg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIlVcUHmHFjBSOXCINokfsQ8IIdpVS0vVQyvtzeThqKm62dDdLeKv8euYyYsuSOXUm6PEiTMPez7PeAZgR6VxnLjM-For7oswDfzE6aI5nCN0VqRB3kRbHKv9M_FlIidr8Ks_C0Nhlf2c2EzU-SyjPfIRAhVc21EgxajowiJOdscf6-8-VZAiT2tfTqMVkUP38wfCt_mHg13k9bsoGu-dft73uwoDfiojtUDt4gWitEIgSOFaiTxIEpLIPE6SIMhT7XiM5mfIhZQF2vp4aVKDIENKZURBm6E4_d-POS6bqEvxJL5hemszZCoPZNC7SLkaXVRVjdIZ0gahEhQKeS-dXqwujP9Yu38Hbd5YBceb8LAzX9mnVt4ewZqrHsPG185B_wSOxpdkzy-zsi6vGDbYyd4pK6dNLSRWVmzupsjLMmPXCNKxxeo23QVrAsUoJvfasaQ-p8OdT-HsTsj5DNarWeVeAAuiTEbCBZGLtdCJMVGYO0oPx6Nci1x5sIM0s90YbQNluLJEWkuktS1pPRj1RLVZl_Scam9c3tLj_dDj_2_f7vlkO9Wf2z-C6sHb4TYqLXliksrNlnMbGsKJhmvuwfOWrcPHEAFryunvQbzC8OEBSgi-eqcqz5vE4NLgqIR8efuw3sAGao49Ojg-3IIH-Dttft9wG9YXV0v3Co2sRfq6kWYG3-5afX4DN3gyfg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Flortaucipir+tau+PET+imaging+in+semantic+variant+primary+progressive+aphasia&rft.jtitle=Journal+of+neurology%2C+neurosurgery+and+psychiatry&rft.au=Makaretz%2C+Sara+J&rft.au=Quimby%2C+Megan&rft.au=Collins%2C+Jessica&rft.au=Makris%2C+Nikos&rft.date=2018-10-01&rft.issn=0022-3050&rft.eissn=1468-330X&rft.volume=89&rft.issue=10&rft.spage=1024&rft_id=info:doi/10.1136%2Fjnnp-2017-316409&rft_id=info%3Apmid%2F28986472&rft.externalDBID=jnnp&rft.externalDocID=jnnp |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3050&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3050&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3050&client=summon |